Kyn Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- December 14, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $49,000,000
Company Info
- Founders
- George Georgiou
- Company Description
- Kyn Therapeutics is a biotechnology company advancing new immunometabolic therapies for cancer. A growing body of research indicates that key metabolites can exert broad suppressive or enhancing effects on the immune system through a complex network of cellular interactions, providing targets for new therapies that could significantly enhance patient response rates to checkpoint inhibitors.
- Market
- Cancer Immunotherapy
- Location
- Cambridge, Massachusetts, USA
- Coinvestors
- Atlas Venture, OrbiMed Advisors